PHASE 1/2A CLINICAL TRIAL OF BI-1206, A MONOCLONAL ANTIBODY TO CD32B (FCVRIIB), IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA THAT HAS RELAPSED OR IS REFRACTORY TO RITUXIMAB
2018-000444-26LINFOMA NO HODGKINIANO DE LINFOCITOS B DE ESCASA MALIGNIDADFundación Jiménez DíazInvestigador: CORDOBA MASCUÑANO RAUL
